Acupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer
Stopped early · Not applicable
Conditions studied: Mucositis, Oropharyngeal Cancer
In brief
Patients are asked to be in this study if have oropharyngeal cancer and will be treated with chemotherapy and radiation. This research is being done to find out if acupuncture can reduce the mouth inflammation and pain caused by chemotherapy and radiation. Chemoradiation may cause mouth inflammation and pain. Acupuncture is a medical technique of inserting very thin needles into the "energy points" on the body with the aim to restore health and well-being. It has been used widely to treat pain, such as lower back pain and joint pain. In this study we will assess the potential usefulness of acupuncture to decrease the severity of mucositis and mucositis-related mouth and throat pain in patients receiving chemoradiation for oropharyngeal cancer. Mouth cancer patients receiving chemoradiation who have not had acupuncture within the last one month and who do not have a history of head and neck cancer may join this pilot study.
Key facts
- Study ID
- NCT01883908
- Run by
- University of Maryland, Baltimore
- People needed
- 4
- Starts
- 2012-12-01
- Expected to finish
- 2015-02-01
- Last updated by the study team
- 2019-11-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Documented diagnosis of oropharyngeal cancer.
- The patient plans on undergoing external beam radiation with concomitant chemotherapy.
- Eastern Cooperative Group in Oncology (ECOG) performance status 0-3.
- Men and women who are ≥ 18 years old
- The patient is aware of the nature of his or her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
You may not qualify if…
- Previous history of head and neck cancer.
- Prior acupuncture within the past month.
- Pre-existing active oral infection
- Life expectancy is < 3 months.
- Plan to go on experimental drug for head and neck cancer in the next 14 weeks.
Where it is running
- University of Maryland Marlene & Stewart Greenebaum Cancer Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.